iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $98.4M invested in iShares US Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 13
Holders
101
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.16M | |
| 2 | +$2.12M | |
| 3 | +$1.7M | |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$991K |
| 5 |
Morgan Stanley
New York
|
+$631K |
Top Sellers
| 1 | -$3.67M | |
| 2 | -$1.06M | |
| 3 | -$465K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$426K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$365K |